Medtronic Aktie News

GALWAY, Ireland, Feb. 11, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, February 17, 2026, for its third quarter of fiscal year 2026, which ended on Friday, January 23, 2026. A news release containing summary financial information will be issued at approximately 5:45 a.m.

High-yielding dividend growth stocks tend to deliver the best long-term performance. Johnson & Johnson and Medtronic both offer dividend yields that are well above the S&P 500.

Eli Lilly's stock price rose sharply as demand for its GLP-1 drugs increased. Novo Nordisk is the second fiddle in GLP-1 drugs, but its GLP-1 pill is seeing strong demand.

RANCHO SANTA MARGARITA, Calif.--(BUSINESS WIRE)--Applied Medical Prevails in Antitrust Jury Trial Against Medtronic.

Medical technology company Medtronic owes rival device manufacturer Applied Medical Resources $382 million in damages for unlawfully monopolizing the market for blood-vessel sealing surgical devices, a jury in federal court in California said in a verdict on Thursday.

AbbVie has successfully hurdled the Humira patent cliff. Medtronic is seeing new growth from smart devices.

Medtronic said on Tuesday it would buy privately held CathWorks in a deal valued at up to $585 million, as it looks to bolster its heart devices portfolio by adding a new diagnostic tool that could improve care standards.

Deal demonstrates Medtronic's commitment to expanding pipeline through strategic investments and targeted acquisitions Exercising option to acquire will bolster Medtronic's interventional cardiology portfolio, expanding its leadership in transforming how cardiovascular disease is diagnosed and treated Medtronic's intent to acquire follows a 2022 strategic partnership agreement with CathWorks GA...